Posts By Alex
-
403Wire StoriesQu�bec Nickel Corp. Announces Closing of the First Tranche of Its Previously Announced Private Placement
VANCOUVER, British Columbia–(BUSINESS WIRE)–Qu�bec Nickel Corp. (CSE: QNI) (�Qu�bec Nickel Corp.� or the �Company�) is pleased to announce that it has completed...
-
400Wire Stories
Qu�bec Nickel Corp. Announces Closing of the First Tranche of Its Previously Announced Private Placement
VANCOUVER, British Columbia–(BUSINESS WIRE)–Qu�bec Nickel Corp. (CSE: QNI) (�Qu�bec Nickel Corp.� or the �Company�) is pleased to announce that it has completed...
-
502Wire StoriesONE Championship Welcomes Stage Front VIP as Global VIP Experience Partner
Experiences for ONE�s U.S. Debut in 2023 to be Announced in Near Future SINGAPORE–(BUSINESS WIRE)–ONE Championship� (ONE), the world�s largest martial arts...
-
512Wire StoriesONE Championship Welcomes Stage Front VIP as Global VIP Experience Partner
Experiences for ONE�s U.S. Debut in 2023 to be Announced in Near Future SINGAPORE–(BUSINESS WIRE)–ONE Championship� (ONE), the world�s largest martial arts...
-
407Wire StoriesLooking for a holiday gift? Choose Rokid Air and feel the thrill of carrying a big screen in your pocket
HANGZHOU, China–(BUSINESS WIRE)–The holiday season is back! How do you get your favorite entertainment whenever, wherever? During the holidays, augmented reality glasses...
-
572Wire StoriesDatopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials
Daiichi Sankyo and AstraZeneca�s TROP2 directed ADC showed an encouraging objective response rate of 32% and a manageable safety profile in patients...
-
604Wire StoriesDatopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials
Daiichi Sankyo and AstraZeneca�s TROP2 directed ADC showed an encouraging objective response rate of 32% and a manageable safety profile in patients...
-
538Wire StoriesTakeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases
? Company to Feature 15 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology ? Oral Presentations Include Updated Results from Phase...
-
588Wire StoriesAzura Ophthalmics Presents Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction at Ophthalmology Innovation Summit XII
TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for...
-
488Wire StoriesInside information: Sievi Capital�s target company Nordic Rescue Group�s subsidiary ceases the manufacturing of rescue lifts
Sievi Capital Plc Inside information 9 December 2022 at 2:00 pm EET Inside information: Sievi Capital�s target company Nordic Rescue Group�s subsidiary...
